Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for METFORMIN HYDROCHLORIDE

Ingredient

METFORMIN HYDROCHLORIDE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-METFORMIN	500MG	TABLET	Resolved	2020-06-25	2020-08-27	118912
TEVA-METFORMIN	850MG	TABLET	Resolved	2020-10-01	2020-10-22	125455
TEVA-METFORMIN	850MG	TABLET	Resolved	2020-01-17	2020-10-22	103584
TEVA-METFORMIN	500MG	TABLET	Resolved	2020-04-03	2020-04-23	110806
TEVA-METFORMIN	850MG	TABLET	Resolved	2023-01-19	2023-04-28	181594
TEVA-METFORMIN	850MG	TABLET	Resolved	2020-04-02	2020-05-14	110649
TEVA-METFORMIN	500MG	TABLET	Resolved	2020-04-03	2020-05-14	110803
TEVA-METFORMIN	500MG	TABLET	Resolved	2020-04-03	2020-06-04	110800
APO-DAPAGLIFLOZIN-METFORMIN	1000MG 5MG	TABLET	Resolved	2024-06-20	2024-08-02	231020
APO-DAPAGLIFLOZIN-METFORMIN	850MG 5MG	TABLET	Resolved	2024-12-05	2024-12-13	244918

1
2
3
…
19
Next

Showing 1 to 10 of 184

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-METFORMIN	500MG	TABLET	Reversed	2025-05-28	2025-06-04	258452

Previous
1
…
3
4
5

Showing 41 to 41 of 41